The Market Reports

Index

1 Urticaria Drug Market Overview
1.1 Product Overview and Scope of Urticaria Drug
1.2 Urticaria Drug Segment by Type
1.2.1 Global Urticaria Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Acute Urticaria
1.2.3 Chronic Urticaria
1.3 Urticaria Drug Segment by Application
1.3.1 Urticaria Drug Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Urticaria Drug Market Size Estimates and Forecasts
1.4.1 Global Urticaria Drug Revenue 2016-2027
1.4.2 Global Urticaria Drug Sales 2016-2027
1.4.3 Urticaria Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Urticaria Drug Market Competition by Manufacturers
2.1 Global Urticaria Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Urticaria Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Urticaria Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Urticaria Drug Manufacturing Sites, Area Served, Product Type
2.5 Urticaria Drug Market Competitive Situation and Trends
2.5.1 Urticaria Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Urticaria Drug Players Market Share by Revenue
2.5.3 Global Urticaria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Urticaria Drug Retrospective Market Scenario by Region
3.1 Global Urticaria Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Urticaria Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Urticaria Drug Market Facts & Figures by Country
3.3.1 North America Urticaria Drug Sales by Country
3.3.2 North America Urticaria Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Urticaria Drug Market Facts & Figures by Country
3.4.1 Europe Urticaria Drug Sales by Country
3.4.2 Europe Urticaria Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Urticaria Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Urticaria Drug Sales by Region
3.5.2 Asia Pacific Urticaria Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Urticaria Drug Market Facts & Figures by Country
3.6.1 Latin America Urticaria Drug Sales by Country
3.6.2 Latin America Urticaria Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Urticaria Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Urticaria Drug Sales by Country
3.7.2 Middle East and Africa Urticaria Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Urticaria Drug Historic Market Analysis by Type
4.1 Global Urticaria Drug Sales Market Share by Type (2016-2021)
4.2 Global Urticaria Drug Revenue Market Share by Type (2016-2021)
4.3 Global Urticaria Drug Price by Type (2016-2021)

5 Global Urticaria Drug Historic Market Analysis by Application
5.1 Global Urticaria Drug Sales Market Share by Application (2016-2021)
5.2 Global Urticaria Drug Revenue Market Share by Application (2016-2021)
5.3 Global Urticaria Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Johnson and Johnson Services
6.1.1 Johnson and Johnson Services Corporation Information
6.1.2 Johnson and Johnson Services Description and Business Overview
6.1.3 Johnson and Johnson Services Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Johnson and Johnson Services Product Portfolio
6.1.5 Johnson and Johnson Services Recent Developments/Updates
6.2 Amneal Pharmaceuticals
6.2.1 Amneal Pharmaceuticals Corporation Information
6.2.2 Amneal Pharmaceuticals Description and Business Overview
6.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amneal Pharmaceuticals Product Portfolio
6.2.5 Amneal Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Taro Pharmaceutical Industries Novartis AG
6.4.1 Taro Pharmaceutical Industries Novartis AG Corporation Information
6.4.2 Taro Pharmaceutical Industries Novartis AG Description and Business Overview
6.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Taro Pharmaceutical Industries Novartis AG Product Portfolio
6.4.5 Taro Pharmaceutical Industries Novartis AG Recent Developments/Updates
6.5 Akorn
6.5.1 Akorn Corporation Information
6.5.2 Akorn Description and Business Overview
6.5.3 Akorn Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Akorn Product Portfolio
6.5.5 Akorn Recent Developments/Updates
6.6 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Corporation Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Teva Pharmaceutical Industries Product Portfolio
6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.7 Genentech
6.6.1 Genentech Corporation Information
6.6.2 Genentech Description and Business Overview
6.6.3 Genentech Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Genentech Product Portfolio
6.7.5 Genentech Recent Developments/Updates
6.8 Xolair
6.8.1 Xolair Corporation Information
6.8.2 Xolair Description and Business Overview
6.8.3 Xolair Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Xolair Product Portfolio
6.8.5 Xolair Recent Developments/Updates

7 Urticaria Drug Manufacturing Cost Analysis
7.1 Urticaria Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Urticaria Drug
7.4 Urticaria Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Urticaria Drug Distributors List
8.3 Urticaria Drug Customers

9 Urticaria Drug Market Dynamics
9.1 Urticaria Drug Industry Trends
9.2 Urticaria Drug Growth Drivers
9.3 Urticaria Drug Market Challenges
9.4 Urticaria Drug Market Restraints

10 Global Market Forecast
10.1 Urticaria Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Urticaria Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Urticaria Drug by Type (2022-2027)
10.2 Urticaria Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Urticaria Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Urticaria Drug by Application (2022-2027)
10.3 Urticaria Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Urticaria Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Urticaria Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Urticaria Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Urticaria Drug Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Urticaria Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Urticaria Drug Covered in This Study
Table 5. Global Urticaria Drug Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Urticaria Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Urticaria Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Urticaria Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Urticaria Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Urticaria Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Urticaria Drug Product Type
Table 12. Global Urticaria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Urticaria Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urticaria Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Urticaria Drug Sales by Region (2016-2021) & (K Units)
Table 16. Global Urticaria Drug Sales Market Share by Region (2016-2021)
Table 17. Global Urticaria Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Urticaria Drug Sales by Country (2016-2021) & (K Units)
Table 19. North America Urticaria Drug Sales Market Share by Country (2016-2021)
Table 20. North America Urticaria Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Urticaria Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Urticaria Drug Sales by Country (2016-2021) & (K Units)
Table 23. Europe Urticaria Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Urticaria Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Urticaria Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Urticaria Drug Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Urticaria Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Urticaria Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Urticaria Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Urticaria Drug Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Urticaria Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Urticaria Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Urticaria Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Urticaria Drug Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Urticaria Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Urticaria Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Urticaria Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Urticaria Drug Sales (K Units) by Type (2016-2021)
Table 39. Global Urticaria Drug Sales Market Share by Type (2016-2021)
Table 40. Global Urticaria Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Urticaria Drug Revenue Share by Type (2016-2021)
Table 42. Global Urticaria Drug Price (US$/Unit) by Type (2016-2021)
Table 43. Global Urticaria Drug Sales (K Units) by Application (2016-2021)
Table 44. Global Urticaria Drug Sales Market Share by Application (2016-2021)
Table 45. Global Urticaria Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Urticaria Drug Revenue Share by Application (2016-2021)
Table 47. Global Urticaria Drug Price (US$/Unit) by Application (2016-2021)
Table 48. Johnson and Johnson Services Corporation Information
Table 49. Johnson and Johnson Services Description and Business Overview
Table 50. Johnson and Johnson Services Urticaria Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Johnson and Johnson Services Urticaria Drug Product
Table 52. Johnson and Johnson Services Recent Developments/Updates
Table 53. Amneal Pharmaceuticals Corporation Information
Table 54. Amneal Pharmaceuticals Description and Business Overview
Table 55. Amneal Pharmaceuticals Urticaria Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Amneal Pharmaceuticals Urticaria Drug Product
Table 57. Amneal Pharmaceuticals Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Urticaria Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Urticaria Drug Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Taro Pharmaceutical Industries Novartis AG Corporation Information
Table 64. Taro Pharmaceutical Industries Novartis AG Description and Business Overview
Table 65. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product
Table 67. Taro Pharmaceutical Industries Novartis AG Recent Developments/Updates
Table 68. Akorn Corporation Information
Table 69. Akorn Description and Business Overview
Table 70. Akorn Urticaria Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Akorn Urticaria Drug Product
Table 72. Akorn Recent Developments/Updates
Table 73. Teva Pharmaceutical Industries Corporation Information
Table 74. Teva Pharmaceutical Industries Description and Business Overview
Table 75. Teva Pharmaceutical Industries Urticaria Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Teva Pharmaceutical Industries Urticaria Drug Product
Table 77. Teva Pharmaceutical Industries Recent Developments/Updates
Table 78. Genentech Corporation Information
Table 79. Genentech Description and Business Overview
Table 80. Genentech Urticaria Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Genentech Urticaria Drug Product
Table 82. Genentech Recent Developments/Updates
Table 83. Xolair Corporation Information
Table 84. Xolair Description and Business Overview
Table 85. Xolair Urticaria Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Xolair Urticaria Drug Product
Table 87. Xolair Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Urticaria Drug Distributors List
Table 91. Urticaria Drug Customers List
Table 92. Urticaria Drug Market Trends
Table 93. Urticaria Drug Growth Drivers
Table 94. Urticaria Drug Market Restraints
Table 95. Global Urticaria Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Urticaria Drug Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Urticaria Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Urticaria Drug Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Urticaria Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Urticaria Drug Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Urticaria Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Urticaria Drug Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Urticaria Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Urticaria Drug Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Urticaria Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Urticaria Drug Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Urticaria Drug
Figure 2. Global Urticaria Drug Market Share by Type in 2020 & 2027
Figure 3. Acute Urticaria Product Picture
Figure 4. Chronic Urticaria Product Picture
Figure 5. Global Urticaria Drug Market Share by Application in 2020 & 2027
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Others
Figure 10. Global Urticaria Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Urticaria Drug Market Size 2016-2027 (US$ Million)
Figure 12. Global Urticaria Drug Sales 2016-2027 (K Units)
Figure 13. Global Urticaria Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Urticaria Drug Sales Share by Manufacturers in 2020
Figure 15. Global Urticaria Drug Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Urticaria Drug Players: Market Share by Revenue in 2020
Figure 17. Urticaria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Urticaria Drug Sales Market Share by Region (2016-2021)
Figure 19. Global Urticaria Drug Sales Market Share by Region in 2020
Figure 20. Global Urticaria Drug Revenue Market Share by Region (2016-2021)
Figure 21. Global Urticaria Drug Revenue Market Share by Region in 2020
Figure 22. U.S. Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Urticaria Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Urticaria Drug by Type (2016-2021)
Figure 47. Sales Market Share of Urticaria Drug by Application (2016-2021)
Figure 48. Sales Market Share of Urticaria Drug by Application in 2020
Figure 49. Revenue Share of Urticaria Drug by Application (2016-2021)
Figure 50. Revenue Share of Urticaria Drug by Application in 2020
Figure 51. Manufacturing Cost Structure of Urticaria Drug
Figure 52. Manufacturing Process Analysis of Urticaria Drug
Figure 53. Urticaria Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed